Use of an Alzheimer's disease polygenic risk score to identify mild cognitive impairment in adults in their 50s.

Published on Mar 1, 2019in Molecular Psychiatry12.384
· DOI :10.1038/S41380-018-0030-8
Mark W. Logue33
Estimated H-index: 33
(BU: Boston University),
Matthew S. Panizzon35
Estimated H-index: 35
(UCSD: University of California, San Diego)
+ 11 AuthorsWilliam S. Kremen70
Estimated H-index: 70
(UCSD: University of California, San Diego)
Sources
Abstract
Author(s): Logue, MW; Panizzon, MS; Elman, JA; Gillespie, NA; Hatton, SN; Gustavson, DE; Andreassen, OA; Dale, AM; Franz, CE; Lyons, MJ; Neale, MC; Reynolds, CA; Tu, X; Kremen, WS | Abstract: Early identification of younger, non-demented adults at elevated risk for Alzheimer's disease (AD) is crucial because the pathological process begins decades before dementia onset. Toward that end, we showed that an AD polygenic risk score (PRS) could identify mild cognitive impairment (MCI) in adults who were only in their 50s. Participants were 1176 white, non-Hispanic community-dwelling men of European ancestry in the Vietnam Era Twin Study of Aging (VETSA): 7% with amnestic MCI (aMCI); 4% with non-amnestic MCI (naMCI). Mean age was 56 years, with 89% l60 years old. Diagnosis was based on the Jak-Bondi actuarial/neuropsychological approach. We tested six P-value thresholds (0.05-0.50) for single nucleotide polymorphisms included in the ADPRS. After controlling for non-independence of twins and non-MCI factors that can affect cognition, higher PRSs were associated with significantly greater odds of having aMCI than being cognitively normal (odds ratios (ORs) = 1.36-1.43 for thresholds P l 0.20-0.50). The highest OR for the upper vs. lower quartile of the ADPRS distribution was 3.22. ORs remained significant after accounting for APOE-related SNPs from the ADPRS or directly genotyped APOE. Diabetes was associated with significantly increased odds of having naMCI (ORs = 3.10-3.41 for thresholds P l 0.05-0.50), consistent with naMCI having more vascular/inflammation components than aMCI. Analysis of sensitivity, specificity, and negative and positive predictive values supported some potential of ADPRSs for selecting participants in clinical trials aimed at early intervention. With participants 15+ years younger than most MCI samples, these findings are promising with regard to efforts to more effectively treat or slow AD progression.
Figures & Tables
Download
📖 Papers frequently viewed together
2,801 Citations
46 Citations
201511.34Brain
225 Citations
References58
Newest
#1Valentina Escott-Price (Medical Research Council)H-Index: 35
#2Amanda J. Myers (UM: University of Miami)H-Index: 53
Last. John HardyH-Index: 186
view all 4 authors...
Previous estimates of the utility of polygenic risk score analysis for the prediction of Alzheimer’s disease have given Area Under the Curve estimates of <80%. However, these have been based on the genetic analysis of clinical case control series. Here we apply the same analytic approaches to a pathological case control series and show a predictive AUC of 84%. We suggest that this analysis has clinical utility and that there is limited room for further improvement using genetic data.
93 CitationsSource
#2Elizabeth A. BootsH-Index: 9
Last. Ozioma C. OkonkwoH-Index: 44
view all 18 authors...
Objective: To examine whether a polygenic risk score (PRS) derived from APOE4, CLU, and ABCA7 is associated with CSF biomarkers of Alzheimer disease (AD) pathology and whether higher cardiorespiratory fitness (CRF) modifies the association between the PRS and CSF biomarkers. Methods: Ninety-five individuals from the Wisconsin Registry for Alzheimer9s Prevention were included in these cross-sectional analyses. They were genotyped for APOE4 , CLU , and ABCA7 , from which a PRS was calculated for e...
28 CitationsSource
#1Yingjia Chen (UC Davis: University of California, Davis)H-Index: 6
#2Katherine Denny (UC Davis: University of California, Davis)H-Index: 9
Last. Laurel A. Beckett (UC Davis: University of California, Davis)H-Index: 89
view all 7 authors...
Abstract Introduction Investigation of the conversion rates from normal cognition (NC) to mild cognitive impairment (MCI) is important, as effective early intervention could potentially prevent or substantially delay the onset of dementia. However, reported conversion rates differ across studies and recruitment source. Our study examined predictors of conversion from NC to MCI in a racially and ethnically diverse sample drawn both from community and clinic recruitment sources. Methods Rates and ...
39 CitationsSource
#1Michael J. Lyons (BU: Boston University)H-Index: 85
#2Matthew S. Panizzon (UC Davis: University of California, Davis)H-Index: 35
Last. Hong Xian (SLU: Saint Louis University)H-Index: 59
view all 13 authors...
: In this longitudinal study we examined the stability of general cognitive ability (GCA), as well as heterogeneity and genetic and environmental influences underlying individual differences in change. We investigated GCA from young adulthood through late midlife in 1,288 Vietnam Era Twin Study of Aging participants at ages ∼20, ∼56, and ∼62 years. The correlations among the 3 occasions ranged from .73 to .85, reflecting substantial stability. The heritability was significant on each of the 3 oc...
30 CitationsSource
#1Giuseppe Tosto (Columbia University)H-Index: 20
#2Thomas D. Bird (UW: University of Washington)H-Index: 116
Last. Richard MayeuxH-Index: 158
view all 22 authors...
Objective: To investigate the association between a genetic risk score (GRS) and familial late-onset Alzheimer disease (LOAD) and its predictive value in families multiply affected by the disease. Methods: Using data from the National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease (National Institute on Aging–Late-Onset Alzheimer9s Disease Family Study), mixed regression models tested the association of familial LOAD with a GRS based on single nucleotide polymorphisms (S...
44 CitationsSource
#1Riccardo E. MarioniH-Index: 60
#2Archie Campbell (Edin.: University of Edinburgh)H-Index: 41
Last. Ian J. DearyH-Index: 184
view all 9 authors...
Stratification by genetic risk factors for Alzheimer's disease (AD) may help identify groups with the greatest disease risk. Biological changes that cause late-onset AD are likely to occur years, if not decades prior to diagnosis. Here, we select a subset of the Generation Scotland: Scottish Family Health Study cohort in a likely preclinical age-range of 60-70 years (subset n = 3,495 with cognitive and genetic data). We test for cognitive differences by polygenic risk scores for AD. The polygeni...
26 CitationsSource
#1Sonya Foley (Cardiff University)H-Index: 14
#2Katherine E. Tansey (UoB: University of Bristol)H-Index: 36
Last. David Edmund Johannes Linden (Cardiff University)H-Index: 79
view all 9 authors...
Background Recent genome-wide association studies have identified genetic loci that jointly make a considerable contribution to risk of developing Alzheimer’s disease (AD). Because neuropathological features of AD can be present several decades before disease onset, we investigated whether effects of polygenic risk are detectable by neuroimaging in young adults. We hypothesized that higher polygenic risk scores (PRSs) for AD would be associated with reduced volume of the hippocampus and other li...
49 CitationsSource
#1Eric Granholm (UCSD: University of California, San Diego)H-Index: 57
#2Matthew S. Panizzon (UCSD: University of California, San Diego)H-Index: 35
Last. William S. Kremen (UCSD: University of California, San Diego)H-Index: 70
view all 9 authors...
: Task-evoked pupillary responses may be a psychophysiological biomarker of early risk for mild cognitive impairment (MCI) and Alzheimer's disease (AD). Pupil dilation during cognitive tasks reflects cognitive effort until compensatory capacity is surpassed and performance declines are manifest, and reflects activation in the locus coeruleus, where degenerative changes have been found in the earliest stages of AD. We recorded pupillary responses during digit span recall in 918 participants ages ...
49 CitationsSource
#1Caleb E. Finch (SC: University of Southern California)H-Index: 113
#2Sara Shams (KI: Karolinska Institutet)H-Index: 18
Alzheimer disease (AD) research has mainly focused on neurodegenerative processes associated with the classic neuropathologic markers of senile plaques and neurofibrillary tangles. Additionally, cerebrovascular contributions to dementia are increasingly recognized, particularly from cerebral small vessel disease (SVD). Remarkably, in AD brains, the apolipoprotein E (ApoE) ɛ4 allele shows male excess for cerebral microbleeds (CMBs), a marker of SVD, which is opposite to the female excess of plaqu...
20 CitationsSource
#2Reisa A. SperlingH-Index: 118
Last. Mert R. SabuncuH-Index: 44
view all 7 authors...
To examine associations between aggregate genetic risk and Alzheimer disease (AD) markers in stages preceding the clinical symptoms of dementia using data from 2 large observational cohort studies.We computed polygenic risk scores (PGRS) using summary statistics from the International Genomics of Alzheimer's Project genome-wide association study of AD. Associations between PGRS and AD markers (cognitive decline, clinical progression, hippocampus volume, and β-amyloid) were assessed within older ...
91 CitationsSource
Cited By63
Newest
#1Gongbu Pan (UTAS: University of Tasmania)
#2Anna E. King (UTAS: University of Tasmania)H-Index: 26
Last. James C. Vickers (UTAS: University of Tasmania)H-Index: 55
view all 7 authors...
Alzheimer's disease (AD) is a complex neurological disorder of uncertain aetiology, although substantial research has been conducted to explore important factors related to risk of onset and progression. Both lifestyle (e.g., complex mental stimulation, vascular health) and genetic factors (e.g., APOE, BDNF, PICALM, CLU, APP, PSEN1, PSEN2, and other genes) have been associated with AD risk. Despite more than thirty years of genetic research, much of the heritability of AD is not explained by mea...
Source
#1Paul W. Franks (Lund University)H-Index: 113
#2Erik Melén (KI: Karolinska Institutet)H-Index: 74
Last. Sara Hägg (KI: Karolinska Institutet)H-Index: 33
view all 33 authors...
The fields of human genetics and genomics have generated considerable knowledge about the mechanistic basis of many diseases. Genomic approaches to diagnosis, prognostication, prevention and treatment - genomic-driven precision medicine (GDPM) - may help optimize medical practice. Here, we provide a comprehensive review of GDPM of complex diseases across major medical specialties. We focus on technological readiness: how rapidly a test can be implemented into health care. Although these areas of...
1 CitationsSource
#1McKenna E. Williams (UCSD: University of California, San Diego)H-Index: 1
#2Jeremy A. Elman (UCSD: University of California, San Diego)H-Index: 15
Last. Nathan A. Gillespie (VCU: Virginia Commonwealth University)H-Index: 35
view all 27 authors...
1 CitationsSource
#1Dimitrios Vlachakis (UoA: National and Kapodistrian University of Athens)H-Index: 19
#2Eleni Papakonstantinou (AUA: Agricultural University of Athens)H-Index: 3
Last. Dimitrios Avramopoulos (JHBMC: Johns Hopkins Bayview Medical Center)H-Index: 47
view all 11 authors...
The treatment of complex and multifactorial diseases constitutes a big challenge in day-to-day clinical practice. As many parameters influence clinical phenotypes, accurate diagnosis and prompt therapeutic management is often difficult. Significant research and investment focuses on state-of-the-art genomic and metagenomic analyses in the burgeoning field of Precision (or Personalized) Medicine with genome-wide-association-studies (GWAS) helping in this direction by linking patient genotypes at ...
Source
Abstract null null This study adds to the literature on the adverse effects of cognitive decline among older adults focusing on financial decisions. The article investigates the impact of objective and subjective memory on the financial decisions of older adults, such as asset holdings, allocation, and financial health. In general, older adults with higher objective memory have better financial outcomes. A higher objective memory leads to greater financial assets including stocks, cash-equivalen...
Source
#1Yingying Zhuang (Nanjing Medical University)H-Index: 1
#2Yuntao Shi (Nanjing Medical University)H-Index: 1
Last. Yun Feng (Nanjing Medical University)H-Index: 1
view all 7 authors...
This study focused on the application of functional magnetic resonance imaging and neuropsychology in diagnosis of vascular mild cognitive impairment (MCI) and the exploration of its relevant factors. The study enrolled 28 patients with vascular MCI in an observation group and 30 healthy individuals in a control group. All patients underwent magnetic resonance imaging. An automatic segmentation algorithm based on graph theory was adopted to process the images. Age, sex, disease course, Montreal ...
1 CitationsSource
#1Yanhui Ding (SDNU: Shandong Normal University)H-Index: 5
#2Kun Zhao (CAS: Chinese Academy of Sciences)H-Index: 28
view all 11 authors...
Growing evidence indicates that amyloid-beta (Aβ) accumulation is one of the most common neurobiological biomarkers in Alzheimer's disease (AD). The primary aim of this study was to explore whether the radiomic features of Aβ positron emission tomography (PET) images are used as predictors and provide a neurobiological foundation for AD. The radiomics features of Aβ PET imaging of each brain region of the Brainnetome Atlas were computed for classification and prediction using a support vector ma...
2 CitationsSource
#1Atul Kumar (Lund University)H-Index: 3
#2Maryam ShoaiH-Index: 14
Last. Oskar Hansson (Lund University)H-Index: 92
view all 7 authors...
Source
#1Su Hyun Shin (UofU: University of Utah)H-Index: 4
#2Soohyun Park (UA: University of Alabama)H-Index: 8
Last. Giyeon Kim (CAU: Chung-Ang University)H-Index: 23
view all 5 authors...
BACKGROUND AND OBJECTIVES This study explored whether the intensity of cognitive activities could moderate the relationship between a genetic predisposition for developing Alzheimer's disease (AD) and cognitive functioning among older adults in the U.S. Further, we examined whether the same moderating effects were dependent on different measures of cognition. RESEARCH DESIGN AND METHODS We used a dataset from the 2000-2014 waves of the Health and Retirement Study and the Consumption and Activiti...
1 CitationsSource
#1Xiaopu ZhouH-Index: 4
#2Yolanda Y. T. LiH-Index: 1
Last. Nancy Y. IpH-Index: 88
view all 4 authors...
The high prevalence of Alzheimer's disease (AD) among the elderly population and its lack of effective treatments make this disease a critical threat to human health. Recent epidemiological and genetics studies have revealed the polygenic nature of the disease, which is possibly explainable by a polygenic score model that considers multiple genetic risks. Here, we systemically review the rationale and methods used to construct polygenic score models for studying AD. We also discuss the associati...
2 CitationsSource